Contact us

5 Results:

Sort By:

Enrollment completed in clinical trial evaluating effect of exclusive human milk diet including a specialty fortifier in term infants born with single ventricle physiology

Type: Press Releases

Topic(s): Single Ventricle Congenital Heart Defects (SVP )

Prolacta Bioscience® to Provide Perspective on the Needs of Newborns With Heart Defects

Type: Press Releases

Topic(s): Single Ventricle Congenital Heart Defects (SVP )

Enrollment Passes Halfway Milestone in Clinical Trial Evaluating the Effect of an Exclusive Human Milk Diet Including a Specialty Fortifier in Term Infants Born with Single Ventricle Congenital Heart Defects

Type: Press Releases

Topic(s): Single Ventricle Congenital Heart Defects (SVP )

Prolacta Formula Fortifier Starts Trial For Newborns With Rare Heart Condition

Type: Prolacta in the News

Topic(s): Clinical Studies Company Single Ventricle Congenital Heart Defects (SVP )

Prolacta Bioscience Initiates Clinical Trial to Evaluate the Effect of a Specially Fortified Exclusive Human Milk Diet to Improve Growth in Infants Born with Single Ventricle Congenital Heart Defect

Type: Press Releases

Topic(s): Clinical Studies Single Ventricle Congenital Heart Defects (SVP )

Not finding the reference you’re looking for?

Email us at info@prolacta.com